Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cryopak Introduces New Line of Shipping Kits | Contract Pharma

What are you searching for?

Sign in

Cryopak Introduces New Line of Shipping Kits

Designed to safely transport infectious substances under Class 6.2, Category B

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cryopak, a provider of temperature-controlled packaging, released its newest shipping system, the STS Cat B. The shipper is designed to safely transport infectious substances under Class 6.2, Category B, and complies with IATA, DOT, TDGR and ICAO regulations.
 
Cryopak developed the kit to address various needs when shipping infectious substances including protecting the specimens to ensure they arrive undamaged, and protecting handlers from the infectious substances during transport.
  
Chief executive officer Maurice Barakat said, “The introduction of Cryopak’s STS Cat B establishes our commitment to reduce customers’ distribution risks related to managing shipments of infectious disease substances, as well as their total costs. Our goal is to facilitate the management of clinical sample shipments with a simple, easy-to-use packaging system.”
 
Cryopak plans to expand its Class 6.2 shipper portfolio to include Category A shipping kits — with and without temperature control — as well as other sizes of Category B STS shippers.
More info: www.cryopak.com

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters